You are here

Market research: stage two - quantitative research report

Informing TGA education and communication activities

11 February 2014

Book pagination

Research results: Knowledge of specific regulatory activities

Awareness of regulatory activities

This research was undertaken in order for us to determine where there are significant knowledge gaps. Industry participants had high levels of knowledge across each of the measures; however, there were mixed responses from the consumer and health professional participants.

Consumers

For consumers, the highest levels of awareness were around recalls and safety alerts. This may be due to the higher levels of media attention they receive, which was identified through the qualitative research stage as a major trigger for consumers to seek further information. Reporting adverse events had the lowest level of awareness, and we have already begun to highlight the importance of adverse event reporting across educational materials targeting consumers.

Figure 6: Consumer awareness levels of specific regulatory activities*

Figure 6: Consumer awareness levels of specific regulatory activities

Top of page

Health professionals

In contrast, the results for health professionals did not show significant differences in levels of awareness between the different activities. However, it is important to note that across all the activities, there were high levels of participants assuming that they occur, as opposed to being aware that they actually do. For each activity, only up to 35 per cent were actually aware, and between 59 per cent and 66 per cent assumed it occurred. The risk with this high level of assumption is that health professionals may not respond to our communications due to the belief they do not contain any new information. Therefore, we must ensure we provide materials that challenge incorrect perceptions and are personally relevant to the health professional audience.

Figure 7: Health professional awareness levels of specific regulatory activities**

Figure 7: Health professional awareness levels of specific regulatory activities

Within this measure, there were some significant differences between the different types of health professionals:

  • GPs were more likely to be somewhat aware that alerts are issued on recalls, safety issues, etc. Allied and complementary health professionals were more likely to be not at all aware.
  • Pharmacists were more likely to assume you can report adverse events to the government, while GPs were more likely to be somewhat aware compared to allied and complementary health professionals.

Awareness of specific TGA practices

Consumers

Consumer participants were asked about their levels of awareness of certain TGA practices.

Figure 8: Consumer awareness of TGA activities***

Figure 8: Consumer awareness of TGA activities

As a result of the low level of awareness of AUST L and AUST R numbers on the packaging of therapeutic goods (and what they mean) we have created educational material on this subject.


*Figure 6 data: Consumer awareness levels of specific regulatory activities

Activity Not sure Not at all aware Assume it occurs Somewhat aware Very aware
Alerts are issued on recalls, safety issues and recommendations about the safe use of therapeutic goods 4 6 14 30 46
Therapeutic goods manufacturers are regulated to ensure they meet acceptable standards of manufacturing quality 5 3 17 32 43
Therapeutic goods are evaluated by government before they are marketed 7 9 14 30 39
Therapeutic goods must be included on a government register before they can be supplied in Australia 9 11 14 28 38
Therapeutic goods are monitored by government once they are on the market 8 11 19 33 30
Therapeutic goods are assessed for the suitability before export from Australia 11 12 18 31 28
Inspectors audit therapeutic goods manufacturing facilities in Australia and around the world to ensure the quality supplied in Australia 10 13 19 32 26
You can report adverse events with therapeutic goods to the government 11 17 16 28 29

**Figure 7 data: Health professional awareness levels of specific regulatory activities

Activity Not at all aware Assume it occurs Somewhat aware Very aware
Therapeutic goods must be included on a government register before they can be supplied in Australia 2 63 23 12
Therapeutic goods are evaluated by government before they are marketed 5 64 21 10
Therapeutic goods are monitored by government once they are on the market 8 61 15 36
Therapeutic goods are assessed for the suitability before export from Australia 8 61 13 18
Therapeutic goods manufacturers are regulated to ensure they meet acceptable standards of manufacturing quality 3 64 21 12
Inspectors audit therapeutic goods manufacturing facilities in Australia and around the world to ensure the quality supplied in Australia 9 63 17 11
Alerts are issued on recalls, safety issues and recommendations about the safe use of therapeutic goods 2 66 22 10
You can report adverse events with therapeutic goods to the government 6 59 23 12

***Figure 8 data: Consumer awareness of TGA activities

Activity Not sure Not at all Slightly aware Moderately Very aware
The consumer medicines information provided with prescription or pharmacist only medicine 8 10 15 32 34
Safety alerts for therapeutic goods 7 14 20 33 26
Recall notices for therapeutic goods 8 14 22 33 23
That you can report an adverse reaction to a therapeutic good 8 20 18 29 25
The conditions that may apply when travelling with medicines 9 17 21 29 24
AUST L or AUST R numbers on the packaging of therapeutic goods 11 50 13 17 9

Top of page

Book pagination